Literature DB >> 15307190

Depletion of NK cells results in disseminating lethal infection with Bordetella pertussis associated with a reduction of antigen-specific Th1 and enhancement of Th2, but not Tr1 cells.

Patricia Byrne1, Peter McGuirk, Stephen Todryk, Kingston H G Mills.   

Abstract

IFN-gamma plays a critical role in protection against Bordetella pertussis, but Th1 cells are only detectable after the infection has started to resolve, suggesting a protective role for innate IFN-gamma early in infection. Here, we demonstrate significant recruitment of NK cells and NKT cells into the lungs following respiratory challenge with B. pertussis. Furthermore, NK cells are the primary source of IFN-gamma in the lungs during the acute stage of infection. Stimulation of IFN-gamma production by NK cells was indirect through B. pertussis-activated IL-12 or IL-23 production by dendritic cells. Depletion of NK cells with anti-asialo ganglio-N-tetraosylceramide antibody resulted in a lethal infection, with enhancement of bacterial load in the lungs and dissemination of the bacteria to the liver via the blood. NK cell-depleted mice had significantly reduced B. pertussis-specific IFN-gamma and enhanced IgG1 and IL-5, but not IL-10 production, suggesting that regulatory T cells are induced simultaneously with Th1 cells, but the absence of NK cells resulted in enhancement of Th2-type responses. These findings suggest that NK cells confer resistance to B. pertussis by activating IL-12-mediated production of IFN-gamma, which enhances the anti-bacterial activity of macrophages, but also promotes the differentiation of Th1 cells. Copyright 2004 Wiley-VCH Verlag GmbH & Co.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15307190     DOI: 10.1002/eji.200425092

Source DB:  PubMed          Journal:  Eur J Immunol        ISSN: 0014-2980            Impact factor:   5.532


  45 in total

1.  Interleukin-1 receptor signaling is required to overcome the effects of pertussis toxin and for efficient infection- or vaccination-induced immunity against Bordetella pertussis.

Authors:  Xuqing Zhang; Sara E Hester; Mary J Kennett; Alexia T Karanikas; Liron Bendor; David E Place; Eric T Harvill
Journal:  Infect Immun       Date:  2010-10-25       Impact factor: 3.441

2.  Bordetella pertussis expresses a functional type III secretion system that subverts protective innate and adaptive immune responses.

Authors:  Neil K Fennelly; Federico Sisti; Sarah C Higgins; Pádraig J Ross; Han van der Heide; Frits R Mooi; Aoife Boyd; Kingston H G Mills
Journal:  Infect Immun       Date:  2008-01-14       Impact factor: 3.441

3.  A critical role for the TLR signaling adapter Mal in alveolar macrophage-mediated protection against Bordetella pertussis.

Authors:  N J Bernard; C M Finlay; G M Tannahill; J P Cassidy; L A O'Neill; K H G Mills
Journal:  Mucosal Immunol       Date:  2014-12-17       Impact factor: 7.313

4.  Natural killer cells support the induction of protective immunity during dendritic cell-mediated vaccination against Leishmania major.

Authors:  Katharina A Remer; Bianca Roeger; Christine Hambrecht; Heidrun Moll
Journal:  Immunology       Date:  2010-12       Impact factor: 7.397

5.  Protection from pneumonic infection with burkholderia species by inhalational immunotherapy.

Authors:  Andrew Goodyear; Lisa Kellihan; Helle Bielefeldt-Ohmann; Ryan Troyer; Katie Propst; Steven Dow
Journal:  Infect Immun       Date:  2009-01-29       Impact factor: 3.441

6.  NK-dependent increases in CCL22 secretion selectively recruits regulatory T cells to the tumor microenvironment.

Authors:  Adam W Mailloux; M Rita I Young
Journal:  J Immunol       Date:  2009-03-01       Impact factor: 5.422

7.  T- and B-cell-mediated protection induced by novel, live attenuated pertussis vaccine in mice. Cross protection against parapertussis.

Authors:  Pascal Feunou Feunou; Julie Bertout; Camille Locht
Journal:  PLoS One       Date:  2010-04-15       Impact factor: 3.240

8.  A live attenuated Bordetella pertussis candidate vaccine does not cause disseminating infection in gamma interferon receptor knockout mice.

Authors:  Ciaran M Skerry; Joseph P Cassidy; Karen English; Pascal Feunou-Feunou; Camille Locht; Bernard P Mahon
Journal:  Clin Vaccine Immunol       Date:  2009-07-22

9.  Differential regulation of GM1 and asialo-GM1 expression by T cells and natural killer (NK) cells in respiratory syncytial virus infection.

Authors:  Martin L Moore; Michael H Chi; Kasia Goleniewska; Joan E Durbin; R Stokes Peebles
Journal:  Viral Immunol       Date:  2008-09       Impact factor: 2.257

10.  Mucosal immunotherapy for protection from pneumonic infection with Francisella tularensis.

Authors:  Ryan M Troyer; Katie L Propst; Jeff Fairman; Catherine M Bosio; Steven W Dow
Journal:  Vaccine       Date:  2009-05-31       Impact factor: 3.641

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.